Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Other financing activities (2023 - 2025)

Historic Other financing activities for Nuvation Bio (NUVB) over the last 3 years, with Q2 2025 value amounting to $166000.0.

  • Nuvation Bio's Other financing activities fell 9737.42% to $166000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 1253.28%. This contributed to the annual value of $17.2 million for FY2024, which is 57220000.0% up from last year.
  • Per Nuvation Bio's latest filing, its Other financing activities stood at $166000.0 for Q2 2025, which was down 9737.42% from $534000.0 recorded in Q1 2025.
  • Over the past 5 years, Nuvation Bio's Other financing activities peaked at $7.6 million during Q4 2024, and registered a low of -$3000.0 during Q4 2023.
  • Over the past 3 years, Nuvation Bio's median Other financing activities value was $1.9 million (recorded in 2024), while the average stood at $3.0 million.
  • Per our database at Business Quant, Nuvation Bio's Other financing activities surged by 25453333.33% in 2024 and then plummeted by 9737.42% in 2025.
  • Over the past 3 years, Nuvation Bio's Other financing activities (Quarter) stood at -$3000.0 in 2023, then surged by 254533.33% to $7.6 million in 2024, then plummeted by 97.83% to $166000.0 in 2025.
  • Its Other financing activities was $166000.0 in Q2 2025, compared to $534000.0 in Q1 2025 and $7.6 million in Q4 2024.